Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Santé Ventures does not develop drugs directly but has invested in numerous early-stage healthcare and life science companies that have achieved successful exits through acquisitions by major industry players such as Boston Scientific, Celgene, IBM, Bristol Myers Squibb, Johnson & Johnson, and Becton Dickinson[4][7].
Example portfolio company outcomes:
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Santé Ventures.